Boston Scientific BSX Endoscopy — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Boston Scientific's endoscopy — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Boston Scientific's endoscopy — net sales?
- Boston Scientific (BSX) reported endoscopy — net sales of $736M in Q1 2026.
- How has Boston Scientific's endoscopy — net sales changed year-over-year?
- Boston Scientific's endoscopy — net sales increased by 9.4% year-over-year, from $673M to $736M.
- What is the long-term trend for Boston Scientific's endoscopy — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's endoscopy — net sales has grown at a 8.0% compound annual growth rate (CAGR), from $2.14B to $2.92B.
- What does endoscopy — net sales mean?
- Total revenue generated from the sale of endoscopy-related medical devices and equipment.
- How do you interpret endoscopy — net sales?
- An increase indicates growing demand for the company's gastrointestinal and pulmonary procedural solutions, while a decrease may signal market saturation or increased competition in the endoscopy space.
- How does endoscopy — net sales compare across companies?
- Comparable to revenue reporting for specialized medical device segments in peer companies focused on gastrointestinal or interventional endoscopy markets.